Showing results (1261-1270 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|March 10, 2022
Amlodipine improves the outcomes of regorafenib in metastatic colorectal cancerCelal Alandağ, Elanur Karaman, Elif Yüce
Anti-Cancer Drugs|March 10, 2022
Biodegradable controlled-release polymer containing butylidenephthalide to treat a recurrent cervical spine glioblastoma with promising result: a compassionate trial reportYan-Hong Pan, Shinn-Zong Lin, Tsung-Lang Chiu
Anti-Cancer Drugs|March 11, 2022
Circ_0003146 upregulates SCARB1 expression by acting as a miR-1272 sponge to promote malignant behaviors of clear cell renal cell carcinomaZongyu Xia, Qin Wang, Peng Lu
Anti-Cancer Drugs|April 26, 2019
Melanoma: the new perspectives from clinical and translational researchMarcella Occelli, Anna M Vandone, Carolina Cauchi, et al.
Anti-Cancer Drugs|August 11, 2018
Osteoblastic bone response mimicking bone progression during treatment with pembrolizumab in advanced cutaneous melanomaFrancesca Comito, Valentina Ambrosini, Francesca Sperandi, et al.
Anti-Cancer Drugs|May 18, 1999
Cyclophosphamide, epirubicin and cisplatin (CEP) versus epirubicin plus cisplatin (EP) in stage Ic-IV ovarian cancer: a randomized phase III trial of the Gynecologic Oncology Group of the Comprehensive Cancer Center LimburgJ Wils, H van Geuns, J Stoot, et al.
Anti-Cancer Drugs|May 18, 1999
Decreased topotecan platelet toxicity with successive topotecan treatment cycles in advanced ovarian cancer patientsF Goldwasser, X Buthaud, M Gross, et al.
Anti-Cancer Drugs|May 18, 1999
An economic evaluation of Tomudex (raltitrexed) and 5-fluorouracil plus leucovorin in advanced colorectal cancerM G Groener, B M van Ineveld, G Byttebier, et al.
Anti-Cancer Drugs|May 18, 1999
Comparative activity of the cyclopropylpyrroloindole compounds adozelesin, bizelesin and carzelesin in a human tumor colony-forming assayM Hidalgo, E Izbicka, C Cerna, et al.
Anti-Cancer Drugs|May 18, 1999
Significant activity of a novel cytotoxic agent, LY295501, against a wide range of tumors in the human tumor cloning systemS G Diab, S G Hilsenbeck, E Izbicka, et al.
Pageof 464